These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 26272609)

  • 1. Inhibition of oncogenic epidermal growth factor receptor kinase triggers release of exosome-like extracellular vesicles and impacts their phosphoprotein and DNA content.
    Montermini L; Meehan B; Garnier D; Lee WJ; Lee TH; Guha A; Al-Nedawi K; Rak J
    J Biol Chem; 2015 Oct; 290(40):24534-46. PubMed ID: 26272609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released from Glioblastoma Cells.
    Choi D; Montermini L; Kim DK; Meehan B; Roth FP; Rak J
    Mol Cell Proteomics; 2018 Oct; 17(10):1948-1964. PubMed ID: 30006486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mapping Subpopulations of Cancer Cell-Derived Extracellular Vesicles and Particles by Nano-Flow Cytometry.
    Choi D; Montermini L; Jeong H; Sharma S; Meehan B; Rak J
    ACS Nano; 2019 Sep; 13(9):10499-10511. PubMed ID: 31469961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab treatment alters the content of extracellular vesicles released from tumor cells.
    van Dommelen SM; van der Meel R; van Solinge WW; Coimbra M; Vader P; Schiffelers RM
    Nanomedicine (Lond); 2016 Apr; 11(8):881-90. PubMed ID: 27021928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Calderwood SK; Okamoto K; Kozaki KI
    Oral Oncol; 2018 Nov; 86():251-257. PubMed ID: 30409309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular vesicle communication pathways as regulatory targets of oncogenic transformation.
    Choi D; Lee TH; Spinelli C; Chennakrishnaiah S; D'Asti E; Rak J
    Semin Cell Dev Biol; 2017 Jul; 67():11-22. PubMed ID: 28077296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway.
    Xu X; Liu Y; Li Y; Chen H; Zhang Y; Liu J; Deng S; Zheng Y; Sun X; Wang J; Chen T; Huang M; Ke Y
    J Exp Clin Cancer Res; 2021 Jan; 40(1):16. PubMed ID: 33407703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation and Interplay between EGFR Signalling and Extracellular Vesicle Biogenesis in Cancer.
    Zanetti-Domingues LC; Bonner SE; Iyer RS; Martin-Fernandez ML; Huber V
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective immunocapture reveals neoplastic human mast cells secrete distinct microvesicle- and exosome-like populations of KIT-containing extracellular vesicles.
    Pfeiffer A; Petersen JD; Falduto GH; Anderson DE; Zimmerberg J; Metcalfe DD; Olivera A
    J Extracell Vesicles; 2022 Sep; 11(10):e12272. PubMed ID: 36239715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukocytes as a reservoir of circulating oncogenic DNA and regulatory targets of tumor-derived extracellular vesicles.
    Chennakrishnaiah S; Meehan B; D'Asti E; Montermini L; Lee TH; Karatzas N; Buchanan M; Tawil N; Choi D; Divangahi M; Basik M; Rak J
    J Thromb Haemost; 2018 Sep; 16(9):1800-1813. PubMed ID: 29971917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-EGFR antibody cetuximab is secreted by oral squamous cell carcinoma and alters EGF-driven mesenchymal transition.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Okamoto K; Calderwood SK; Kozaki KI
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1267-1272. PubMed ID: 30017201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles derived from inflamed murine colorectal tissue induce fibroblast proliferation via epidermal growth factor receptor.
    Hasegawa K; Kuwata K; Yoshitake J; Shimomura S; Uchida K; Shibata T
    FEBS J; 2021 Mar; 288(6):1906-1917. PubMed ID: 32894891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer Cell-derived Exosomes Induce Mitogen-activated Protein Kinase-dependent Monocyte Survival by Transport of Functional Receptor Tyrosine Kinases.
    Song X; Ding Y; Liu G; Yang X; Zhao R; Zhang Y; Zhao X; Anderson GJ; Nie G
    J Biol Chem; 2016 Apr; 291(16):8453-64. PubMed ID: 26895960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
    Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
    Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of phosphoproteomics to uncover oncogenic signalling in secreted extracellular vesicles using glioblastoma-EGFRVIII cells as a model.
    Bijnsdorp IV; Schelfhorst T; Luinenburg M; Rolfs F; Piersma SR; de Haas RR; Pham TV; Jimenez CR
    J Proteomics; 2021 Feb; 232():104076. PubMed ID: 33307249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B; Chang CM; Yuan M; McKenna WG; Shu HK
    Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of gefitinib treatment on cellular uptake of extracellular vesicles in EGFR-mutant non-small cell lung cancer cells.
    Takenaka T; Nakai S; Katayama M; Hirano M; Ueno N; Noguchi K; Takatani-Nakase T; Fujii I; Kobayashi SS; Nakase I
    Int J Pharm; 2019 Dec; 572():118762. PubMed ID: 31610280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor promotes glioma progression by regulating xCT and GluN2B-containing N-methyl-d-aspartate-sensitive glutamate receptor signaling.
    Suina K; Tsuchihashi K; Yamasaki J; Kamenori S; Shintani S; Hirata Y; Okazaki S; Sampetrean O; Baba E; Akashi K; Mitsuishi Y; Takahashi F; Takahashi K; Saya H; Nagano O
    Cancer Sci; 2018 Dec; 109(12):3874-3882. PubMed ID: 30298963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nuclear transportation of exogenous epidermal growth factor receptor and androgen receptor via extracellular vesicles.
    Read J; Ingram A; Al Saleh HA; Platko K; Gabriel K; Kapoor A; Pinthus J; Majeed F; Qureshi T; Al-Nedawi K
    Eur J Cancer; 2017 Jan; 70():62-74. PubMed ID: 27886573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Vesicle Activation of Latent HIV-1 Is Driven by EV-Associated c-Src and Cellular SRC-1 via the PI3K/AKT/mTOR Pathway.
    Barclay RA; Mensah GA; Cowen M; DeMarino C; Kim Y; Pinto DO; Erickson J; Kashanchi F
    Viruses; 2020 Jun; 12(6):. PubMed ID: 32575590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.